Xiaolin Wang - 17 Sep 2021 Form 4 Insider Report for Revolution Medicines, Inc. (RVMD)

Role
EVP, Clinical Development
Signature
/s/ Jack Anders, as Attorney-in-fact for Xiaolin Wang
Issuer symbol
RVMD
Transactions as of
17 Sep 2021
Transactions value $
-$7,505
Form type
4
Filing time
21 Sep 2021, 19:47:40 UTC
Previous filing
22 Jun 2021
Next filing
21 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVMD Common Stock Sale -$7.51K -250 -2.01% $30.02 12.2K 17 Sep 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.
F2 Includes 9,800 RSUs.

Remarks:

EVP, Clinical Development